Premier Financial Statements From 2010 to 2024
| BIEI Stock | USD 0.0008 0.0001 11.11% |
Check Premier Biomedical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Premier Biomedical's main balance sheet or income statement drivers, such as , as well as many indicators such as . Premier financial statements analysis is a perfect complement when working with Premier Biomedical Valuation or Volatility modules.
Premier |
Premier Biomedical Company Shares Outstanding Analysis
Premier Biomedical's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Premier Biomedical Shares Outstanding | 999.98 M |
Most of Premier Biomedical's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Premier Biomedical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Premier Biomedical has 999.98 M of shares currently outstending. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The shares outstanding for all United States stocks is 74.88% lower than that of the firm.
Premier Biomedical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Premier Biomedical's current stock value. Our valuation model uses many indicators to compare Premier Biomedical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Premier Biomedical competition to find correlations between indicators driving Premier Biomedical's intrinsic value. More Info.Premier Biomedical is number one stock in return on asset category among its peers. It also is number one stock in operating margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Premier Biomedical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Premier Biomedical's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Premier Biomedical Financial Statements
Investors use fundamental indicators, such as Premier Biomedical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Premier Biomedical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Premier Biomedical, Inc., a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. Premier Biomedical, Inc. was founded in 2010 and is headquartered in Jackson Center, Pennsylvania. Premier Biomedical is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in Premier Pink Sheet
Premier Biomedical financial ratios help investors to determine whether Premier Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Premier with respect to the benefits of owning Premier Biomedical security.